AFP and Mistral AI announce global partnership to enhance AI responses with reliable news content

Agence France-Presse (AFP) and Mistral AI have formed a partnership that will provide Mistral's conversational AI assistant, Le Chat, with access to the full range of AFP's text stories. This collaboration will allow users to receive more informed and up-to-date responses, underpinned by content that meets the highest journalistic standards. 

Agence France-Presse (AFP) and Mistral AI have formed a partnership that will provide Mistral's conversational AI assistant, Le Chat, with access to the full range of AFP's text stories. This collaboration will allow users to receive more informed and up-to-date responses, underpinned by content that meets the highest journalistic standards. 
Anglais
Neymar… still on a World Cup roll
09/17/2025 14:35

Bacardi Limited, the world’s largest privately held international spirits company, announces several internal moves, underscoring the company’s global approach to leadership development and a commitment to talent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917778482/en/Bacardi announces new roles for Dave Ingram and Nicole Zukowski. Dave Ingram has been appointed to the role of Chief People & Business Transformation Offic...

07/22/2025 06:32
KIOXIA Announces Industry’s First 245.76 TB NVMe SSD Built for the Demands of Generative AI Environments

Kioxia Corporation has expanded its high-capacity KIOXIA LC9 Series enterprise SSD lineup by introducing the industry’s first[1] 245.76 terabyte (TB)[2] NVMe™ SSD in 2.5-inch and EDSFF E3.L form factor. This new capacity and form factor option complements the previously announced 122.88 TB (2.5-inch) model and is purpose-built for the performance and efficiency demands of generative AI environments. This press release features multimedia. View the full release here: https://www.businesswire.co...

07/31/2025 10:00
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) designation to the Company’s investigational Bruton’s tyrosine kinase (BTK) degrader, BGB-16673, for the treatment of patients with Waldenstrom’s macroglobulinemia (WM) previously treated with a BTK inhibitor. “This is the Company’s first PRIME designation, marking a milestone for BeOne and providing early and ...

Subscribe to